Nuclear factor erythroid 2-related factor 2 — Drug Target

All drugs that target Nuclear factor erythroid 2-related factor 2 — marketed and clinical-stage.

Marketed (1)

• Skyclarys · Biogen Us · Other
  Skyclarys works by activating the Nrf2 pathway to increase the production of antioxidant proteins that protect cells from damage.